How are antibiotics classified?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Classification

Antibiotics are classified using multiple complementary systems: the WHO AWaRe framework (Access, Watch, Reserve) for stewardship purposes, first-choice versus second-choice designations for clinical selection, and traditional categorization by mechanism of action (cell wall inhibitors, protein synthesis inhibitors, nucleic acid inhibitors, membrane-active agents). 1

WHO AWaRe Framework (Primary Classification for Stewardship)

The WHO uses a traffic-light approach to categorize 257 antibiotics globally into three groups based on resistance potential and appropriate use 1:

Access Group (Green Light)

  • Narrow-spectrum agents with favorable risk-benefit ratios and low resistance levels 1
  • Should be widely available, affordable, and of assured quality in all healthcare facilities 1
  • Recommended as empiric first- or second-choice treatment for common clinical infections 1
  • Lower resistance potential compared to other groups 1

Watch Group (Orange Light)

  • Broader-spectrum agents with higher resistance potential and greater toxicity concerns 1
  • Includes highest priority critically important antimicrobials such as fluoroquinolones and carbapenems 1
  • Should be key targets of antimicrobial stewardship and monitoring programs 1
  • Often first- or second-choice for specific indications but require careful monitoring 1
  • Generally associated with more adverse events and higher cost 1

Reserve Group (Red Light)

  • Last-resort options for multidrug-resistant organisms (MDROs) 1
  • Only eight antibiotics identified in this category 1
  • Should be used exclusively for confirmed or suspected infections when other alternatives have failed 1
  • Show consistent activity against organisms resistant to first- and second-choice options 1
  • Major targets for antimicrobial stewardship programs with mandatory monitoring 1

Clinical Selection Framework

First-Choice Antibiotics

  • Usually narrow-spectrum agents with benefits outweighing risks 1
  • Relatively low levels of reported resistance 1
  • Preferred initial empiric therapy for specific indications 1

Second-Choice Antibiotics

  • Generally broader-spectrum agents with higher resistance rates or less favorable risk-benefit ratios 1
  • Used when first-choice options are inadequate or contraindicated 1

Important caveat: The first/second-choice level and AWaRe categories are independent systems—a Watch antibiotic may be first-choice for certain infections 1

Mechanism of Action Classification

Antibiotics are traditionally organized by their cellular targets 2, 3:

Cell Wall Inhibitors

  • β-lactams (penicillins, cephalosporins, carbapenems, monobactams) interfere with bacterial cell wall biosynthesis 4, 5
  • Differ in stability to β-lactamases and antimicrobial spectrum 4

Protein Synthesis Inhibitors

  • Target bacterial ribosomal machinery 3, 5
  • Include aminoglycosides and macrolides 3

Nucleic Acid Inhibitors

  • Fluoroquinolones inhibit DNA gyrase and topoisomerase IV, preventing DNA replication, transcription, repair, and recombination 6
  • Different mechanism from β-lactams, aminoglycosides, and macrolides, allowing activity against bacteria resistant to those classes 6, 7, 6

Membrane-Active Antibiotics

  • Disrupt bacterial cell membrane integrity 3

Susceptibility Classification

Bacteria are categorized based on laboratory testing 1:

Susceptible (S)

  • Pathogen likely inhibited if antimicrobial reaches usual achievable blood concentrations 1
  • Defined by minimum inhibitory concentration (MIC) breakpoints 1

Intermediate (I)

  • Variable response to therapy; may respond if drug is concentrated at infection site or dosage increased 1
  • Provides technical buffer zone preventing minor variations from causing interpretation errors 1

Resistant (R)

  • Microbiological resistance: Organisms possess resistance mechanisms demonstrated phenotypically or genotypically 1
  • Clinical resistance: Infection highly unlikely to respond even to maximum antibiotic doses 1
  • May be qualified as low-level, moderate, or high-level resistance 1

Spectrum Classification

Antibiotics are characterized by their range of activity 1:

  • Gram-positive, Gram-negative, aerobic, facultatively anaerobic, or obligate anaerobes 1
  • Acquired resistance alters spectrum patterns over time and location 1

Cross-Resistance Patterns

  • Complete or partial insusceptibility to antibiotic groups 1
  • Strictly applies to same chemical class (e.g., β-lactams, aminoglycosides, macrolides) 1
  • Resistance mechanisms like impermeability or efflux may affect multiple classes (associated resistance) 1

Clinical pitfall: Fluoroquinolone resistance develops slowly through multiple mutations (10⁻⁹ to 10⁻¹⁰ frequency), with cross-resistance between fluoroquinolones but not with other antibiotic classes 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antibiotic classification: implications for drug selection.

Critical care nursing quarterly, 1997

Research

[Classes of antibiotics and their mechanisms of action].

Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1977

Research

β-lactam antibiotics: An overview from a medicinal chemistry perspective.

European journal of medicinal chemistry, 2020

Research

Antibiotics: Precious Goods in Changing Times.

Methods in molecular biology (Clifton, N.J.), 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.